Based in Portugal, Chartwell Actives, LLC. is an API scientific and business team specializing in fermentation, downstream processing and chemical synthesis. The team has decades of combined experience in GMP applied to API manufacturing, research and development, engineering, quality control, quality assurance, and regulatory affairs in a US FDA and an EU Evaluation of Medicinal Products (EMEA) environment. By integrating the API, Finished Dose Forms (FDF), and commercialization chain, Chartwell will be able to meet the needs of a growing market for hard-to-find, complex drugs being developed for commercial approval.
The Actives team is a cornerstone of Chartwell's vertical expansion, with relationships in the US, EU, and Asian markets.